Insiders Genmab A/S Nasdaq

Equities

GMAB

US3723032062

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-07 EDT			5-day change	1st Jan Change
27.77 ^USD	-2.73%		-1.52%	-12.78%

06-04	Truist Securities Raises Price Target on Genmab to $53 From $50, Maintains Buy Rating	MT
06-03	Genmab's Tisotumab Shows 'Encouraging' Antitumor Activity in Phase 2 Head, Neck Cancer Study	MT

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Genmab A/S Announces Executive Changes	03-13	CI
Danish Biotechnology Group Genmab Names New Chief Strategy Officer	23-03-28	MT
Genmab A/S Announces Appointment of Martine van Vugt to Chief Strategy Officer and Promotes to Executive Vice President Effective March 29, 2023	23-03-28	CI
Avantor Names Jonathan Peacock Chairman	22-05-13	MT
Genmab A/S Elects Elizabeth O’Farrell to the Board of Directors	22-03-29	CI
Genmab Announces the Nomination of a New Member of the Company's Board of Directors	22-03-15	AQ
Genmab A/S : Announces the Nomination of a New Member of the Company’s Board of Directors - Form 6-K	22-03-14	PU
Genmab Announces the Nomination of a New Member of the Company’s Board of Directors	22-03-14	GL
Genmab Appoints New Chief Legal Officer, Chief People Officer	22-03-01	MT
Genmab A/S Announces Appointments of Birgitte Stephensen to Chief Legal Officer and Chris Cozic to Chief People Officer	22-03-01	CI
Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created Position of Chief Medical Officer, Head of Experimental Medicines	21-02-22	CI
Genmab A/S Appoints Pernille Erenbjerg as Deputy Chairman	20-03-26	CI
Genmab A/S Announces the Election of Mr. Jonathan Peacock to its Board of Directors for a One-Year Period	20-03-26	CI
Genmab A/S Announces Anthony Mancini Will Join the Company as Executive Vice President and Chief Operating Officer, Effective March 23, 2020	20-03-10	CI
Genmab' Chairman of the Board of Directors, Mats Pettersson to Step Down from the Board At Annual General Meeting on March 26, 2020	20-02-21	CI
Genmab A/S Announces Executive Changes	19-10-30	CI
Genmab A/S Announces Management Changes	19-03-11	CI
Genmab A/S Appoints Judith Klimovsky as Executive Vice President and Chief Development Officer, Effective February 13, 2017	17-02-08	CI
Genmab A/S Nominates Rolf Hoffmann to its Board of Directors	16-08-03	CI
Genmab A/S Announces Board Appointments	15-03-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

GENMAB : A good start to 2024; guidance unchanged

May 03, 2024 at 01:08 pm